Adline Chem Lab

13.33
0.00
(0.00%)
ann
There are new updates from the company21 hours ago
Viewcross
right
Market Cap
7.80 Cr
EPS
-0.25
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
26.01
52 Week Low
9.40
PB Ratio
-5.23
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,700.60
#1 4,08,030.90
34.30
#1 49,887.20
12.06
#1 9,648
13.77
39.51
6,126.00
1,62,626.05
76.30
8,184.00
0.89
1,600
#1 64.53
51.01
1,529.70
1,23,540.86
24.47
26,520.70
14.17
4,155
47.38
51.85
3,241.70
1,09,713.86
58.85
10,785.70
11.59
1,656
13.54
50.18
2,545.00
1,05,001.24
50.48
10,615.60
19.57
1,942
-16.38
54.46
1,219.60
1,01,770.18
#1 17.64
28,905.40
12.36
5,578
21.14
57.97
2,097.10
95,741.20
32.49
20,141.50
#1 19.94
1,936
38.82
50.20
900.00
90,561.06
19.63
19,831.50
13.82
3,831
29.92
51.79
1,234.10
71,676.73
19.87
29,559.20
17.55
3,169
-10.04
53.36
30,320.00
64,427.88
47.84
6,097.20
10.80
1,201
16.01
48.74
Growth Rate
Revenue Growth
-100.00 %
Net Income Growth
-97.62 %
Cash Flow Change
-300.00 %
ROE
-96.83 %
ROCE
-96.98 %
EBITDA Margin (Avg.)
-2,437.79 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
15
17
17
8
6
7
6
1
1
0
0
Expenses
14
17
16
7
5
10
7
1
1
0
0
EBITDA
1
1
1
1
1
-3
-0
-0
0
-0
-0
Operating Profit %
6 %
3 %
7 %
11 %
11 %
-51 %
-4 %
-40 %
0 %
0 %
0 %
Depreciation
1
0
1
1
1
0
1
0
0
0
0
Interest
1
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
-4
-1
1
-4
-0
-0
Tax
0
0
0
0
0
0
0
0
0
0
-0
Net Profit
0
0
0
0
0
-4
-1
1
-4
-0
-0
EPS in ₹
0.04
0.02
0.01
0.00
0.05
-6.45
-2.19
1.23
-7.24
-0.25
0.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
19
18
21
23
22
8
6
5
0
0
Fixed Assets
10
10
13
13
12
5
4
4
0
0
Current Assets
7
7
8
11
10
3
2
0
0
0
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
8
8
8
11
10
3
2
0
0
0
Total Liabilities
19
18
21
23
22
8
6
5
0
0
Current Liabilities
6
7
10
12
15
4
3
2
1
2
Non Current Liabilities
6
5
4
4
0
0
0
0
0
0
Total Equity
7
7
7
7
7
3
2
3
-2
-2
Reserve & Surplus
1
1
1
1
1
-3
-4
-3
-7
-8
Share Capital
6
6
6
6
6
6
6
6
6
6

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
-0
-0
2
-2
-0
-0
0
0
0
Investing Activities
-2
-0
-3
-0
-0
11
0
0
0
0
Operating Activities
0
1
3
1
-1
-11
-0
0
0
0
Financing Activities
2
-1
1
1
-0
0
0
0
0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
31.46 %
31.46 %
30.45 %
30.17 %
30.17 %
30.17 %
28.24 %
28.24 %
28.24 %
28.24 %
28.24 %
28.24 %
29.61 %
29.61 %
29.61 %
29.61 %
29.61 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
58.27 %
58.27 %
59.27 %
59.28 %
59.29 %
59.29 %
61.25 %
61.51 %
61.51 %
61.52 %
61.53 %
61.63 %
60.29 %
60.30 %
60.32 %
60.15 %
60.13 %
Others
10.28 %
10.28 %
10.28 %
10.55 %
10.54 %
10.54 %
10.52 %
10.25 %
10.25 %
10.24 %
10.23 %
10.14 %
10.10 %
10.09 %
10.07 %
10.24 %
10.26 %
No of Share Holders
18,705
18,704
18,704
18,700
18,695
18,689
18,686
18,678
18,670
18,661
18,638
18,628
18,595
18,583
18,536
18,509
18,514

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
09 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 May 2025 12.82 13.07
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 19.10 18.00
16 Jan 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
16 Jan 2025 19.25 20.09
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 26.01 24.99
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 18.01 20.00
30 Sept 2021 CHANGE OF NAME Change Of Name
NA
30 Sept 2021 0.00 0.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication21 hours ago
Financial Results For March 31 20253 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 09.05.20253 days ago
Board Meeting Intimation for The Quarter And Financial Year Ended March 31 202510 days ago
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 02, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 22, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 12, 2025
Board Meeting Outcome for Appointment Of Additional DirectorsApr 12, 2025
Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 11, 2025
Board Meeting Intimation for Appointment Of Additional Directors.Apr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 24, 2025
Integrated Filing (Financial)Feb 12, 2025
Disclosure Regarding Submission Of Application Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Re-Classification Of PromotersFeb 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Results For Quarter And Nine Months Ended On 31St December 2024.Feb 04, 2025
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Adline Chem Lab Limited Held On 4Th February 2025Feb 04, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 17, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJan 16, 2025
NON-APPLICABILITY OF STATEMENT OF DEVIATION & VARIATION UNDER REGULATION 32 OF SEBI (LODR) REGULATIONS 2015Jan 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Intimation For Change Of Name Of Registrar & Share Transfer Agent Of The CompanyJan 01, 2025
Closure of Trading WindowDec 27, 2024
Extract Of Board Meeting Held On Wednesday, 11Th December, 2024Dec 11, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateDec 11, 2024
Board Meeting Outcome for Outcome Of Board Meeting To Be Held 11Th December, 2024Dec 11, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held 11Th December, 2024Dec 04, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 21, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 21, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Intimation Pertaining To Requests Received For Reclassification Of Shareholding From 'Promoter And Promoter Group' Category To 'Public' Category As Per Regulation 31A Of SEBI (LODR) Regulations, 2015Nov 15, 2024
Results For Financial Results For Quarter And Half Year Ended 30Th September, 2024.Nov 13, 2024
Non Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter And Half Year Ended On 30Th September, 2024Nov 13, 2024
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Adline Chem Lab LimitedNov 13, 2024
Board Meeting Intimation for Intimation Regarding Postponement Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 26, 2024
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 22, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Oct 04, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 30, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 28, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Closure of Trading WindowSep 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 31, 2024
Reg. 34 (1) Annual Report.Aug 30, 2024
Outcome Of The Board Meeting For AGM Related AgendasAug 24, 2024
Board Meeting Outcome for Outcome And Disclosure Under Regulation 30 Of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 ('Listing Regulations')Aug 24, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 23, 2024
Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Aug 16, 2024

Technical Indicators

RSI(14)
Neutral
48.04
ATR(14)
Less Volatile
0.54
STOCH(9,6)
Overbought
100.00
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.64
ADX(14)
Strong Trend
34.06
UO(9)
Bearish
80.09
ROC(12)
Uptrend And Accelerating
30.05
WillR(14)
Overbought
0.00